2022. Study of the Association between Plasminogen Activator Inhibitor-1, other Inflammatory Markers, Metabolic Control Parameters, and Diabetic Foot Disease. Biomedical Research and Therapy. 9, 3 (Mar. 2022), 4986–4995. DOI:https://doi.org/10.15419/bmrat.v9i3.733.